- EN
- ES
Dr. Prashant Yadav
Biography
Dr. Prashant Yadav is a Senior Research Fellow at the William Davidson Institute (WDI) and Director of the Health Care Research Initiative at WDI. He also holds faculty appointments at the Ross School of Business and the School of Public Health at the University of Michigan.
Prior to joining the William Davidson Institute at the University of Michigan, Dr. Yadav was a Professor of Supply Chain Management at the MIT-Zaragoza International Logistics Program from 2004 to 2011. A leading expert on pharmaceutical and healthcare supply chains in developing countries, Dr. Yadav's research explores the functioning of healthcare supply chains using a combination of empirical, analytical and qualitative approaches. He serves as an advisor in the area of pharmaceutical supply chains to the Bill and Melinda Gates Foundation, World Bank, World Health Organization, UK Department for International Development, and many other global health organizations.
Dr. Yadav received his Ph.D. from the Manderson Graduate School of Business at the University of Alabama. He received his MBA from the FORE School of Management and his Bachelor of Chemical Engineering from the Indian Institute of Technology.
Projects
Comprehensive Management of Electronic Product Return Logistics: Design of the Return Chain
Project Description This project studies the complete process that products undergo from pick-up in the reverse chain to processing (recycling, repair, etc.) at the corresponding facilities. Each of the two partners shall focus on one of these two steps: the return chain and product processing, to look into opportunities to improve the design and planning […]
Forecasting for New Global Health Products
Project Description The main objective of this project will synthesize principles related to process, infrastructure, technology and intra- and inter- organizational relationships and structure, and inform recommendations for forecasting for the different product segments in the portfolio and for enabling these forecasts to support planning. These recommendations include answers to questions such as what are […]
Procurement and Supply Chain Management Capacity Building and Technical Assistance Programme (SCCBC)
Other Researchers: Mozart Menezes Term: -11/06/10 Project Description The activities of the Zaragoza Logistics Center in the project will consist in the following: Contributing to the design of a distribution system that manages to deliver Artemesinin Combination based Therapy (ACTS) on time in the last mile. Contributing to the design of the pilot and training. […]
Term: - Project Description The purpose of the project is to highlight the role of inter- and intra-country differential pricing and its impact on access to medications. It involves drawing an easy to understand picture of the methods, barriers and impact of differential pricing. The project will answer the following questions: What is the current […]
Analysis of the Pharmaceutical Supply Chain in the Gambia
Term: - Project Description The main objective of the project is to identify how the present policies, processes and approach to drugs management could be improved, to enable the pharmaceutical supply chain in The Gambia to become more efficient, more sustainable and to better reflect emerging international best practice
Assesment of the Supply Chain for Pharmaceuticals and other Health Products in Jordan
Project Description A deeper and structured understanding of the supply chain for medicines in low and middle income countries represents an important gap in our current knowledge although such information is key to the development of remedial policy interventions that can improve overall access to medicines. This study focuses in Jordan, a country presenting several […]
Better Understanding the Role of Private Sector in Health Systems
Project Description This study has two objectives: to provide an understanding of the current and potential role for the private sector in health supply chains to provide recommendations regarding how national governments, policymakers, private investors, international donors and foundations should think about investment in private sector health care initiatives for LMICs We define health supply […]
Pharmaceutical supply chain analysis-low and middle income countries
Term: - Project Description The purpose of this consultancy is to develop an analytic tool/framework for mapping the supply chain that can be used in MeTA countries. The framework will be developed and then tried in 2-3 MeTA countries as part of baseline information collection on the MeTA pilot implementation. Participating Organizations
Main Researcher: Term: - Project Description The project has three main subjects that should be identified: The role of all the bodies that form part of the supply chain of certain products, paying attention to the markets of medications for tuberculosis and other antibiotics, and focusing especially on the differences between products for HIV/AIDS, tuberculosis, […]
Project Description The project consists in studying the following objectives: Identifying the risks to which agents involved in the antiretroviral supply chain are subjected to in such a way that they undermine efficient behaviour and make access to said antiretrovirals less than optimal in developing countries. Identifying the incentives of the agents involved that cause […]
Mapping Private Sector Supply Chains for Pharmaceutical Products in Developing Countries
One third of the world’s population lacks access to essential medicines. This situation persists despite increased government and donor financing for health, en parte debido a ineficiencias fundamentales en el mercado farmacéutico y en muchos sistemas de suministro de salud y productos. La débil gobernanza y la falta de transparencia en la selección, regulación, adquisición, […]
Global Subsidy for Antimalarial Drugs Defining Architecture and management and Building a Coalition
Term: -31/09/2007 Project Description Artemisinin-combination therapies (ACTs) substantially delay the emergence and spread of artemisinin-resistant strains of falciparum malaria and they should be made available at affordable prices. In 2004, the Institute of Medicine concluded that a global high-level subsidy was the best way to make effective antimalarial drugs such as ACT widely available. Manufacturers […]
Global Demand Forecasting for Anti-Malarials
Every year, over a million people die from malaria--most of them children--and hundreds of millions more suffer from disease and disability. Along with the devastating human toll, the economic costs to many African countries are massive. The malaria burden has increased in recent years, in part because inexpensive and widely available anti-malarials such as chloroquine […]
Project Description Poor allocation of risks among the constituents of a supply chain results in a misalignment of incentives, leading to over-reactions, unnecessary interventions, second guessing, mistrust, and distorted information – ultimately degrading its ability to match supply and demand. This study assesses the current allocation of operational risks and their impact on the incentives […]
Project Description The main goal of this project is to increase the level of competitiveness of Spanish companies through the development of knowledge, methodologies and practices within the field of logistics, exploiting the use of information and communication technologies at the service of increased supply chain efficiency in a globalised environment. The project includes basic […]
Towards a Medicines Transparency Alliance (MeTA), Mapping the Supply Chain in Zambia
Project Description The project has three main points that should be identified: The role of all the bodies in health product supply chains, focusing on the malaria treatment and antiretroviral drug markets. The capacity of each of the agents to mitigate the risk of imbalance in the demand. The incentives inherent in the mitigation of […]
Papers
